Log in
Enquire now

List of Summa Health System patents

List of Summa Health System patents
List of Front Edge Technology patents
List of Bridgewater Systems patents
List of DSO National Laboratories patents
Clinical Studies Sponsored by University of Minnesota
Subscription box venture capital investors
Patents where
Current Assignee
Name
is
Summa Health SystemSumma Health System
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7091241 Nontoxic potentiation/sensitization of cancer therapy by supplementary treatment with combined vitamins C and K

Patent 7091241 was granted and assigned to Summa Health System on August, 2006 by the United States Patent and Trademark Office.

Summa Health System
Summa Health System
United States Patent and Trademark Office
United States Patent and Trademark Office
7091241
August 15, 2006
‌
US Patent 9050265 Vitamin C and vitamin K, and compositions thereof for treatment of osteolysis or prolongation of prosthetic implant

Patent 9050265 was granted and assigned to Summa Health System on June, 2015 by the United States Patent and Trademark Office.

Summa Health System
Summa Health System
United States Patent and Trademark Office
United States Patent and Trademark Office
9050265
June 9, 2015
‌
US Patent 9687275 Method and apparatus for pelvic visceral manipulation by surgical robot

Patent 9687275 was granted and assigned to Summa Health System on June, 2017 by the United States Patent and Trademark Office.

Summa Health System
Summa Health System
United States Patent and Trademark Office
United States Patent and Trademark Office
9687275
June 27, 2017
‌
US Patent 10384040 Sump port drain adapter

Patent 10384040 was granted and assigned to Summa Health System on August, 2019 by the United States Patent and Trademark Office.

Summa Health System
Summa Health System
Summa Health System
Summa Health System
United States Patent and Trademark Office
United States Patent and Trademark Office
10384040
August 20, 2019
‌
US Patent 8507555 Non-toxic anti-cancer drug combining ascorbate, magnesium and a naphthoquinone

Patent 8507555 was granted and assigned to Summa Health System on August, 2013 by the United States Patent and Trademark Office.

Summa Health System
Summa Health System
United States Patent and Trademark Office
United States Patent and Trademark Office
8507555
August 13, 2013
‌
US Patent 8751254 Method and apparatus for monitoring and systematizing rehabilitation data

Summa Health System
Summa Health System
United States Patent and Trademark Office
United States Patent and Trademark Office
8751254
June 10, 2014
6 results
0 selected
6 results
0 selected
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us

Explore companies

  • Artificial Intelligence
  • Fintech
  • Biotechnology
  • Cybersecurity
  • Semiconductors
  • Electric Vehicles
  • Cloud Computing
  • Robotics
  • SaaS
  • Renewable Energy
  • Venture Capital
  • Blockchain
  • Browse all →